WEE1 Cancer Research Results

WEE1, WEE1 G2 Checkpoint Kinase: Click to Expand ⟱
Source:
Type:

WEE1 - WEE1 G2 Checkpoint Kinase

Abbreviation: WEE1

Type: Protein kinase / cell-cycle checkpoint kinase / DNA-damage response regulator

Function: WEE1 inhibits cyclin-dependent kinases, particularly CDK1 and CDK2, through inhibitory phosphorylation. This restrains S-phase progression and G2/M transition, prevents premature mitotic entry, stabilizes replication forks, and allows time for DNA-damage repair.

Cancer: ↑ WEE1 is frequently overexpressed or functionally relied upon in cancer cells, particularly tumors with defective TP53-dependent G1 checkpoint control. Increased WEE1 activity helps cancer cells tolerate replication stress and DNA damage by delaying cell-cycle progression and permitting repair.

Favorable Direction in Cancer: ↓ WEE1 activity is generally favorable in WEE1-dependent cancers because checkpoint inhibition can increase replication stress, prevent adequate DNA repair, force premature mitotic entry, and promote mitotic catastrophe and cancer-cell death.

Interpretation Note: WEE1 also has normal genome-protective functions in non-cancerous cells. Its cancer-promoting role is therefore best understood as tumor cells exploiting an otherwise protective checkpoint mechanism.



Scientific Papers found: Click to Expand⟱
9185- BITC,  PEITC,  AITC,  ITCs,    Effects of Brassicaceae Isothiocyanates on Prostate Cancer
- Review, Pca, NA
antiOx↑, Inflam↓, Bacteria↓, chemoPv↑, TumCCA↑, Apoptosis↑, ChemoSen↑, TumCP↓, TumCI↓, TumMeta↓, DNMTs↓, HDAC↓, HDAC6↓, AR↓, selectivity↑, CDK1↓, CycB/CCNB1↓, P53↑, WEE1↑, CDC25↓, cMyc↓, cycD1/CCND1↓, cycE/CCNE↓, CDK4↓, CDK6↓, XIAP↓, survivin↓, Bcl-2↓, compIII↓, APAF1↑, ROS↑, OXPHOS↓, MMP↓, Ca+2↑, CXCR4↓, IL6↓, JAK2↓, STAT3↓, mTOR↓, Synergy↑, CSCs↓, uPAR↓, NF-kB↓, TGF-β↓, angioG↓,
8237- LCA,    Role of Licochalcone A in Potential Pharmacological Therapy: A Review
- Review, Var, NA
*other↝, *Inflam↓, *Bacteria↓, *antiOx↑, *AntiP↑, *neuroP↑, *glucose↝, *lipid-P↓, PKCδ↓, P70S6K↓, Akt↓, ER Stress↑, Apoptosis↑, Ca+2↑, PI3K↓, mTOR↓, Casp3↑, Bcl-2↓, Cyt‑c↑, BAX↑, cl‑PARP↑, cycD1/CCND1↑, ROS↑, CHOP/DDIT3↑, ERK↑, p38↑, JNK↓, IAP1↓, XIAP↓, survivin↓, cFLIP↓, RIP1↓, EGFR↓, MET↓, HER2/EBBR2↓, p‑4E-BP1↓, PERK↑, eIF2α↑, PD-L1↓, HK2↓, Glycolysis↓, Sp1/3/4↓, FasL↑, MMP↓, ATP↓, TumAuto↑, WEE1↑, P21↑, CDK1↓, TumCCA↑, TumCMig↓, TumCI↓, ABCG2↓, HSP90↓, T-Cell↑, CD4+↑, CD25+↑, FOXP3↑, Imm↝, *Inflam↓, *NF-kB↓, *NRF2↑, *AntiArt↑, *antiAll↑, *MUC5AC↓, *E-sel↓, *CCL11↓,
8244- LCA,    Licochalcone A from licorice root, an inhibitor of human hepatoma cell growth via induction of cell apoptosis and cell cycle arrest
- in-vitro, Liver, HepG2
TumCP↓, ROS↑, TumCCA↑, Apoptosis↑, survivin↓, CycB/CCNB1↓, CDK1↓, WEE1↑, P21↑, cycD1/CCND1↑, JNK↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, Casp3↑, Casp8↑, Casp10↑, Fas↑, BAD↑, BAX↑, PUMA↑, PKCδ↓, P70S6K↓, Akt↓,
8898- MOR,    Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells
- in-vitro, Cerv, HeLa
TumCP↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, WEE1↑, CDK1↓, CDC25↓, survivin↓, CycB/CCNB1↓, Chk2↓, BAX↑, BAD↑, Cyt‑c↑, APAF1↑, Casp9↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, Casp10↑, PARP↑, PI3K↑, Akt↑, mTOR↑, p70S6↑, Diablo↑, Bcl-2↓, Bcl-xL↓, AMPK↓, IAP1↓, NF-kB↓, ROS↑,

Showing Research Papers: 1 to 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   ROS↑, 4,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC25↓, 2,   compIII↓, 1,   OXPHOS↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

AMPK↓, 1,   ATP↓, 1,   Glycolysis↓, 1,   HK2↓, 1,  

Cell Death(tgid=5) ⓘ

APAF1↑, 2,   Apoptosis↑, 4,   BAD↑, 2,   BAX↑, 3,   Bcl-2↓, 3,   Bcl-xL↓, 1,   Casp10↑, 2,   Casp3↑, 2,   Casp8↑, 1,   Casp9↑, 1,   cFLIP↓, 1,   Cyt‑c↑, 2,   Diablo↑, 1,   DR5↑, 2,   FADD↑, 1,   Fas↑, 1,   FasL↑, 2,   IAP1↓, 2,   p38↑, 1,   PUMA↑, 1,   survivin↓, 4,   XIAP↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 1,   EGFR↓, 1,   ERK↑, 1,   HER2/EBBR2↓, 1,   JAK2↓, 1,   JNK↓, 1,   JNK↑, 1,   mTOR↓, 2,   mTOR↑, 1,   p70S6↑, 1,   P70S6K↓, 2,   PI3K↓, 1,   PI3K↑, 1,   PKCδ↓, 2,   RIP1↓, 1,   Sp1/3/4↓, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

cMyc↓, 1,   DNMTs↓, 1,   HDAC↓, 1,   HDAC6↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 1,   eIF2α↑, 1,   ER Stress↑, 1,   HSP90↓, 1,   PERK↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

P53↑, 2,   PARP↑, 1,   cl‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 4,   CDK4↓, 1,   CDK6↓, 1,   Chk2↓, 1,   CycB/CCNB1↓, 3,   cycD1/CCND1↓, 1,   cycD1/CCND1↑, 2,   cycE/CCNE↓, 1,   P21↑, 3,   TumCCA↑, 4,   WEE1↑, 4,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   CSCs↓, 1,   TumCP↓, 3,  

Migration(tgid=13) ⓘ

Ca+2↑, 2,   MET↓, 1,   TGF-β↓, 1,   TumCI↓, 2,   TumCMig↓, 1,   TumMeta↓, 1,   uPAR↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MMP↓, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 1,   CXCR4↓, 1,   FOXP3↑, 1,   IL6↓, 1,   Imm↝, 1,   Inflam↓, 1,   NF-kB↓, 2,   PD-L1↓, 1,   T-Cell↑, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   ChemoSen↑, 1,   selectivity↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AR↓, 1,   EGFR↓, 1,   HER2/EBBR2↓, 1,   IL6↓, 1,   PD-L1↓, 1,  

Functional Outcomes(tgid=23) ⓘ

chemoPv↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,  
Total Targets: 108

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   lipid-P↓, 1,   NRF2↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

glucose↝, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

other↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

E-sel↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MUC5AC↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   Inflam↓, 2,   NF-kB↓, 1,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 1,   AntiArt↑, 1,   neuroP↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiP↑, 1,   Bacteria↓, 1,  
Total Targets: 15

Scientific Paper Hit Count for: WEE1, WEE1 G2 Checkpoint Kinase
2 Licochalcone A
1 Benzyl isothiocyanate
1 Phenethyl isothiocyanate
1 Allyl isothiocyanate
1 Isothiocyanates
1 Morin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:1790  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page